IntriCon Secures National Health Service Product Approval
17 September 2015 - 11:00PM
Business Wire
Company Set to Launch High-Quality Hearing
Aid Line in the United Kingdom
IntriCon Corporation (NASDAQ: IIN), a designer,
developer, manufacturer and distributor of miniature and
micro-miniature body-worn devices, today announced that it has
received final approval from the United Kingdom’s National Health
Service (NHS) Audiology Supplies Group for its high-quality hearing
aid products.
In partnership with PC Werth Ltd, IntriCon’s hearing aids will
be distributed to the NHS under PC Werth’s Kamplex brand name. PC
Werth, who has a long-standing relationship with the NHS, will
provide the required marketing, selling, training and service
support.
“NHS approval is an important milestone in our value hearing
health initiative, and we are eager to begin a U.K. rollout,” said
Mark S. Gorder, president and chief executive officer of IntriCon.
“Furthermore, this approval speaks volumes to the quality and
performance of our hearing aids products and fitting software, as
the NHS adheres to rigorous and stringent standards. And given
their strong U.K. market presence and extensive experience with the
NHS, we are also excited to move forward with PC Werth.”
Gorder indicated that the NHS is the largest purchaser of
hearing aids in the world, supplying an estimated 1.4 million
hearing aids annually. While at this time, it is difficult to
forecast the financial impact of the program, potential is
significant given the NHS’ scale. A targeted rollout of Kamplex
hearing aid products will begin this month, followed by a more
extensive rollout in the 2016.
Said Tom Parker, managing director of PC Werth, “Like IntriCon,
we are delighted with the approval. We believe the introduction of
hearing aids under the Kamplex brand has a strong synergy with our
existing range of diagnostic audiological equipment and accessories
that we provide to the NHS. Having this complete service package
will support hearing aid sales and benefit our NHS customers.”
Concluded Gorder, “The NHS is widely recognized as the most
efficient hearing aid delivery system in the world. And we believe
that our high-quality devices are well positioned to further
enhance their model and improve access. Beyond IntriCon’s
value-added devices, we are actively developing fitting solutions
that help audiology services increase efficiency, while also
enhancing the standard of hearing health delivered to
patients.”
About PC WerthEstablished in 1947 by Peter Werth, PC
Werth played an instrumental role establishing the UK’s independent
hearing healthcare sector and was instrumental in developing the UK
business for three of the World’s six largest hearing aid
manufacturers. Now a leading supplier of hearing healthcare
products and equipment to the NHS and all hearing healthcare
practitioners, PC Werth also supplies communication products and
associated services to schools and learning establishments.
Operating nationwide from offices in London, PC Werth provides a
genuinely personal and nationwide service to hearing healthcare
professionals, and delivers group communication solutions for
environments where the fundamentals of communication and hearing is
of primary importance. Find out more at www.pcwerth.co.uk.
About IntriCon CorporationHeadquartered in Arden Hills,
Minn., IntriCon Corporation designs, develops and manufactures
miniature and micro-miniature body-worn devices. These advanced
products help medical, healthcare and professional communications
companies meet the rising demand for smaller, more intelligent and
better connected devices. IntriCon has facilities in the United
States, Asia and Europe. The company’s common stock trades under
the symbol “IIN” on the NASDAQ Global Market. For more information
about IntriCon, visit www.intricon.com.
Forward-Looking StatementsStatements made in this release
and in IntriCon’s other public filings and releases that are not
historical facts or that include forward-looking terminology are
“forward-looking statements” within the meaning of the Securities
Exchange Act of 1934, as amended. These forward-looking statements
may be affected by known and unknown risks, uncertainties and other
factors that are beyond IntriCon’s control, and may cause
IntriCon’s actual results, performance or achievements to differ
materially from the results, performance and achievements expressed
or implied in the forward-looking statements. These risks,
uncertainties and other factors are detailed from time to time in
the company’s filings with the Securities and Exchange Commission,
including the Annual Report on Form 10-K for the year ended
December 31, 2014. The company disclaims any intent or obligation
to publicly update or revise any forward-looking statements,
regardless of whether new information becomes available, future
developments occur or otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150917005236/en/
At IntriCon:Scott Longval, CFO,
651-604-9526slongval@intricon.comorAt PadillaCRT:Matt Sullivan,
612-455-1700matt.sullivan@padillacrt.com
Intricon (NASDAQ:IIN)
Historical Stock Chart
From Apr 2024 to May 2024
Intricon (NASDAQ:IIN)
Historical Stock Chart
From May 2023 to May 2024